At 2.4% CAGR, the Middle East & Africa Cardiopulmonary Oxygenator Market is projected to be worth US$ 35.49 million by 2028, says The Business Market Insights

According to the Business Market Insights’ research, the Middle East & Africa cardiopulmonary oxygenator market was valued at US$ 30.74 million in 2022 and is expected to reach US$ 35.49 million by 2028, registering a CAGR of 2.4% from 2022 to 2028. Use of portable extracorporeal membrane oxygenation in lung transplant procedures and Increasing usage of cardiopulmonary oxygenators in pediatric and neonatal patients are the critical factors attributed to the Middle East & Africa cardiopulmonary oxygenator market expansion.                    

The first ECMO technology was introduced in more than 60 years. The first marketed model was huge in size and shape. Even today, ECMO machines need a proper space allocated in operating rooms for transplant and open-heart surgeries, due to which, patients and physicians may encounter space constraints and other challenges. Physicians also face difficulties setting up the machine and connecting them to patients. These challenges may lead to the wastage of much time, leading to a greater risk to the patient’s life.

With the introduction of a portable version of the ECMO system, doctors are now feeling at ease while treating patients suffering from chronic COPD or heart failure. The new portable technology is revolutionary due to its compact size; it is also an ideal choice in left ventricular assist device (LVAD) therapy or lung transplant. The portable machine gives the physician enough time to access the patient's organ situation. Small portable machines are beneficial for patients undergoing more than one organ transplant. Thus, portable ECMO machines are emerging as a futuristic trend in the cardiopulmonary oxygenators market.

Some ECMO systems are intended for intra-hospital transport, while some are meant for inter-hospital patient transport. Even during transport, the portable systems allow adequate oxygenation to the patient and CO2 reduction to optimize organ perfusion. The Getinge ECMO systems are small and lightweight heart-lung support systems. In January 2019, Terumo Cardiovascular Group, a global leader in cardiovascular surgery technologies, announced the launch of its smallest full-size adult oxygenator—Capiox NX19 Oxygenator with UltraPrime technology. The new Capiox NX19 oxygenator helps minimize the impact of cardiopulmonary bypass by reducing hemodilution, minimizing inflammatory response, and aiding highly efficient gaseous microemboli (GME) removal.

On the contrary, lack of skilled professionals hurdles the growth of Middle East & Africa cardiopulmonary oxygenator.

Based on product, the Middle East & Africa cardiopulmonary oxygenator market is bifurcated into membrane oxygenator and bubble oxygenator. The membrane oxygenator segment held 91.8% market share in 2022, amassing US$ 28.23 million. It is projected to garner US$ 32.80 million by 2028 to expand at 2.5% CAGR during 2022–2028.

Based on application, the Middle East & Africa cardiopulmonary oxygenator market is bifurcated into cardiac and respiratory. The cardiac segment held 67.9% market share in 2022, amassing US$ 20.86 million. It is projected to garner US$ 25.00 million by 2028 to expand at 3.1% CAGR during 2022–2028. Further, cardiac is segmented into acute myocardial infarction, myocarditis, post-transplant complications, decompensated cardiomyopathy, and others. Further, respiratory is segmented into respiratory failure, acute respiratory distress syndrome, pulmonary embolism, pneumonia, and COVID-19.

Based on type, the Middle East & Africa cardiopulmonary oxygenator market is bifurcated into reusable cardiopulmonary oxygenators and disposable cardiopulmonary oxygenators. The reusable cardiopulmonary oxygenators segment held 91.4% market share in 2022, amassing US$ 28.09 million. It is projected to garner US$ 32.58 million by 2028 to expand at 2.5% CAGR during 2022–2028.

Based on Age Group, the Middle East & Africa cardiopulmonary oxygenator market is segmented into adults, pediatric, and neonates. The adults segment held 71.5% market share in 2022, amassing US$ 21.99 million. It is projected to garner US$ 25.63 million by 2028 to expand at 2.6% CAGR during 2022–2028.

Based on end use, the Middle East & Africa cardiopulmonary oxygenator market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held 79.6% share in North America Cardiopulmonary Oxygenator market in 2022, amassing US$ 24.48 million. It is projected to garner US$ 28.46 million by 2028 to expand at 2.5% CAGR during 2022–2028.

Based on country, the Middle East & Africa cardiopulmonary oxygenator market has been categorized into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa.  Our regional analysis states that Saudi Arabia captured 45.8% market share in 2022. It was assessed at US$ 14.09 million in 2022 and is likely to hit US$ 15.80 million by 2028, exhibiting a CAGR of 1.9% during the forecast period.     

Key players dominating the Middle East & Africa cardiopulmonary oxygenator market Getinge AB; LivaNova Plc; Medtronic Plc; Terumo Corp; Microport Scientific Corp; Chalice Medical Ltd; Fresenius Medical Care AG & Co KGaA among others.   

• In Jan 2021, 15 Day Approval for the Paragon Maxi PMP
• In Feb 2020, FDA clears Fresenius Medical Care’s Novalung for treatment of acute respiratory and cardiopulmonary failure

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com